Induction therapy in kidney transplants is initiated in immunologically high risk patients.The therapy prevents the episodes of rejection and helps in graft survival.Rabbit ATG(Anti thymocyte immunoglobulin)which is commonly instituted is costly and it escalates the overall cost of transplant therapy ,if it can be replaced by cheaper time tested alternative it willl be very useful in developing and poor countries.Horse ATG is an efficacious and affordable option which can be used in these conditions.
No takes yet. Share an insight, caveat, or question.
NAVVA et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: